CLAIM #64398 · AvePoint, Inc. (AVPT) · 2022Q2 earnings call · Aug 11, 2022 · due Dec 31, 2022
“We actually sold more migration product in the first half than we were anticipating...and we saw that in really Q1 and Q2, and we're expecting to see that continue for the second half of the year.”
Jim Caci · CFO
How to check this claim
Look at: Migration product sales mix / continued elevated migration product sales relative to plan, as disclosed in management commentary
It came true if: Company continues to report higher-than-anticipated migration product sales impacting ARR in Q3 and Q4 2022 (directional: elevated migration mix persists through second half)
Where: Management commentary on Q3 and Q4 2022 earnings calls / ARR guidance discussion
In context
“e prudent and conscientious of that. And really, when you think about it, that's what we've built into thinking about the second half of the year. Those were two key factors in our thinking. FX obviously, the headwind on the more global macroeconomic environment that we're in right now, geopolitical influences, trying to be conservative to a certain degree, but also taking that into account and reflecting that in what we expect to deliver and then what obviously we're sharing in terms of guidance. And then maybe the third thing that is also influencing our kind of thinking internally, and those first two are definitely much more macro-driven. And the third one is maybe a little bit more internally focused, where we're seeing a lot more of our customers and the mix in terms of product mix. We actually sold more migration product in the first half than we were anticipating, which has an impact for us, and I think you and I have talked about this, we don't include migration in our ARR. So that product since the mix shifted, and we actually sold more which was great, our customers were demanding it, and we were there to satisfy it, but it obviously has an impact on ARR. And we saw that in really Q1 and Q2, and we're expecting to see that continue for the second half of the year. So we've also brought that into our thinking and kind of adjusted our guidance even on ARR to include both the first two macro conditions and then also the third, which is a little bit more specific to us. So we've kind of factored all of those things into our thinking. Tianyi Jiang: Yes, thanks for the question. I just want to comment on, overall, the macro conditions that Jim outlined are things that we cannot control, but things that we can control. So I just came back from Tori in EMEA, our”
Verify independently
SEC filings for AVPT ↗ · Claim quote is verbatim from the 2022Q2 earnings call.